These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 28323033)

  • 21. Metronomic chemotherapy: Back to the future!
    André N; Padovani L; Verschuur A
    Drug News Perspect; 2010 Mar; 23(2):143-51. PubMed ID: 20369080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimizing Chemotherapeutic Anti-cancer Treatment and the Tumor Microenvironment: An Analysis of Mathematical Models.
    Ledzewicz U; Schaettler H
    Adv Exp Med Biol; 2016; 936():209-223. PubMed ID: 27739050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-dose metronomic chemotherapy: from past experience to new paradigms in the treatment of cancer.
    Loven D; Hasnis E; Bertolini F; Shaked Y
    Drug Discov Today; 2013 Feb; 18(3-4):193-201. PubMed ID: 22868084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adaptive therapy.
    Gatenby RA; Silva AS; Gillies RJ; Frieden BR
    Cancer Res; 2009 Jun; 69(11):4894-903. PubMed ID: 19487300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Minimal PK/PD model for simultaneous description of the maximal tolerated dose and metronomic treatment outcomes in mouse tumor models.
    Terterov IN; Chubenko VA; Knyazev NA; Klimenko VV; Bogdanov AA; Moiseyenko VM; Bogdanov AA
    Cancer Chemother Pharmacol; 2021 Nov; 88(5):867-878. PubMed ID: 34351468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metronomic chemotherapy for cancer treatment: a decade of clinical studies.
    Romiti A; Cox MC; Sarcina I; Di Rocco R; D'Antonio C; Barucca V; Marchetti P
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):13-33. PubMed ID: 23475105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metronomic chemotherapy using orally active carboplatin/deoxycholate complex to maintain drug concentration within a tolerable range for effective cancer management.
    Mahmud F; Chung SW; Alam F; Choi JU; Kim SW; Kim IS; Kim SY; Lee DS; Byun Y
    J Control Release; 2017 Mar; 249():42-52. PubMed ID: 28093298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mathematical modelling for the assessment of the effect of drug application delays in metronomic chemotherapy of cancer due to physiological constraints.
    Mukherjee A; Majumder D
    Biosystems; 2008 Jan; 91(1):108-16. PubMed ID: 17889991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metronomic dose-finding approach in oral chemotherapy by experimentally-driven integrative mathematical modeling.
    Kweon S; Jeong YS; Chung SW; Lee H; Lee HK; Park SJ; Choi JU; Park J; Chung SJ; Byun Y
    Biomaterials; 2022 Jul; 286():121584. PubMed ID: 35617783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor Microenvironment.
    Kerbel RS
    Cancer J; 2015; 21(4):274-83. PubMed ID: 26222079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can targeted therapy be successful without metronomic scheduling?
    André N; Pasquier E; Kamen B
    Curr Top Med Chem; 2012; 12(15):1639-42. PubMed ID: 22978340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metronomic chemotherapy in cancer treatment: new wine in an old bottle.
    Wu HL; Zhou HX; Chen LM; Wang SS
    Theranostics; 2024; 14(9):3548-3564. PubMed ID: 38948068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of low-dose metronomic chemotherapy in dogs-insight into a modern cancer field.
    Gaspar TB; Henriques J; Marconato L; Queiroga FL
    Vet Comp Oncol; 2018 Mar; 16(1):2-11. PubMed ID: 28317239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential role of metronomic chemotherapy in the treatment of esophageal and gastroesophageal cancer.
    Noronha V; Patil VM; Joshi A; Chougule A; Banavali S; Prabhash K
    Cancer Lett; 2017 Aug; 400():267-275. PubMed ID: 28109908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metronomic therapy: chemotherapy revisited.
    Noronha V; Krishna MV; Patil V; Joshi A; Banavali SD; Prabhash K
    Indian J Cancer; 2013; 50(2):142-8. PubMed ID: 23979206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemotherapeutic Dose Scheduling Based on Tumor Growth Rates Provides a Case for Low-Dose Metronomic High-Entropy Therapies.
    West J; Newton PK
    Cancer Res; 2017 Dec; 77(23):6717-6728. PubMed ID: 28986381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maximum tolerated dose versus metronomic scheduling in the treatment of metastatic cancers.
    Benzekry S; Hahnfeldt P
    J Theor Biol; 2013 Oct; 335():235-44. PubMed ID: 23850479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metronomic chemotherapy in hematology: Lessons from preclinical and clinical studies to build a solid rationale for future schedules.
    Banchi M; Cox MC; Bocci G
    Cancer Lett; 2024 Jun; 591():216900. PubMed ID: 38636896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanoparticle-mediated metronomic chemotherapy in cancer: A paradigm of precision and persistence.
    Kirti A; Simnani FZ; Jena S; Lenka SS; Kalalpitiya C; Naser SS; Singh D; Choudhury A; Sahu RN; Yadav A; Sinha A; Nandi A; Panda PK; Kaushik NK; Suar M; Verma SK
    Cancer Lett; 2024 Jul; 594():216990. PubMed ID: 38801886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A mathematical model for the administration of temozolomide: comparative analysis of conventional and metronomic chemotherapy regimens.
    Faivre C; Barbolosi D; Pasquier E; André N
    Cancer Chemother Pharmacol; 2013 Apr; 71(4):1013-9. PubMed ID: 23389760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.